Get notified when QUCY files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (new) — Company disclosed substantial doubt about ability to continue operating due to recurring losses, negative cash flows, and working capital deficit.
  • Material Weakness (new) — Company disclosed material weaknesses in internal controls including inadequate policies, documentation, system access, and segregation of duties.
  • Asset Impairment (new) — Company recorded $2.6 million impairment on intellectual property related to discontinued colorectal cancer product lines.
  • Related Party (new) — Company sold its European Oncology Lab business to a related party as part of restructuring efforts.
NASDAQ: QUCY Quantum Cyber N.V. 10-K

Quantum Cyber exits colorectal cancer, pivots to pancreatic screening and cybersecurity

Filed March 31, 2026 · Period ending December 31, 2025 · ~1 min read

Key Changes

  • high

    Company discontinued ColoAlert and next-gen colorectal cancer products in February 2026, selling IP and terminating all German employees. Revenue-generating CRC business eliminated entirely to focus on pancreatic cancer detection.

    Business: Strategic pivot verify on EDGAR →
  • high

    David Lazar invested $6M for preferred shares representing 95%+ ownership on fully diluted basis upon shareholder approval. Appointed co-CEO alongside new Chairman Robert Liscouski as company pivots to post-quantum cybersecurity.

    Business: Lazar investment verify on EDGAR →
  • high

    Cash declined 86% to $889K at year-end 2025 with $1.9M working capital deficit and $104.9M accumulated deficit. Auditor raised substantial doubt about ability to continue as going concern.

    MD&A: Liquidity verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade QUCY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify